Company Search:
Advanced Search
Sponsored Links
Cynata Therapeutics Ltd Company Snapshot
Cynata Therapeutics Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cynata Therapeutics Ltd with three other companies in this sector in Australia: Antisense Therapeutics Limited (2017 sales of 140,169.00 Australian Dollars [US$109,080.92 ] ), Vectus Biosystems Ltd (48,841.00 Australian Dollars [US$38,008.55 ] ), and CropLogic Ltd (125,452.88 Australian Dollars [US$97,628.69 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Cynata Therapeutics Ltd
  Stock Performance Chart for Cynata Therapeutics Ltd
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 1.40
(Figures in Australian Dollars)
1 Week 1.4%   13 Weeks 3.3%  
4 Weeks 137.3%   52 Weeks 191.7%  
Cynata Therapeutics Ltd Key Data:
  Ticker: CYP Country: Australia
  Exchanges: Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 94,231
(Year Ending Jan 2018).
Employees: N/A
  Currency: Australian Dollars Market Cap: 126,080,147
  Fiscal Yr Ends: June Shares Outstanding: 90,057,248
  Share Type: Units Closely Held Shares: 21,479,022
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.